Health
WeightWatchers Cuts Jobs, Weighs Selling Copycat Obesity Drugs
This article is for subscribers only.
WW International Inc., better known as WeightWatchers, is laying off employees and cutting costs as blockbuster obesity drugs have decimated its business.
The New York company is now “investigating” selling compounded versions of weight-loss drugs made by Eli Lilly & Co. and Novo Nordisk A/S, Chief Executive Officer Sima Sistani said on a conference call with analysts Thursday. The company previously said it was “wholeheartedly against this path” on its website earlier this week.